Xiang BD - Search Results

1

Distribution of tumor stage and initial treatment modality in patients with primary hepatocellular carcinoma.

Xiang X, Zhong JH, Wang YY, You XM, Ma L, Xiang BD, Li LQ. Xiang X, et al. Among authors: xiang bd. Clin Transl Oncol. 2017 Jul;19(7):891-897. doi: 10.1007/s12094-017-1621-6. Epub 2017 Feb 3. Clin Transl Oncol. 2017. PMID: 28160206

2

Adjuvant therapy options following curative treatment of hepatocellular carcinoma: a systematic review of randomized trials.

Zhong JH, Li H, Li LQ, You XM, Zhang Y, Zhao YN, Liu JY, Xiang BD, Wu GB. Zhong JH, et al. Among authors: xiang bd. Eur J Surg Oncol. 2012 Apr;38(4):286-95. doi: 10.1016/j.ejso.2012.01.006. Epub 2012 Jan 24. Eur J Surg Oncol. 2012. PMID: 22281155 Review.

3

Letter: pre- and post-operative anti-viral therapy is important for patients with hepatitis B virus-related hepatocellular carcinoma.

Zhong JH, Xiang BD, Li LQ. Zhong JH, et al. Among authors: xiang bd. Aliment Pharmacol Ther. 2015 Apr;41(8):789-90. doi: 10.1111/apt.13098. Aliment Pharmacol Ther. 2015. PMID: 25781042 Free article. No abstract available.

4

Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma.

Wang YY, Zhong JH, Su ZY, Huang JF, Lu SD, Xiang BD, Ma L, Qi LN, Ou BN, Li LQ. Wang YY, et al. Among authors: xiang bd. Br J Surg. 2016 May;103(6):725-734. doi: 10.1002/bjs.10095. Epub 2016 Mar 23. Br J Surg. 2016. PMID: 27005482

5

Repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma: retrospective multicentre study.

Zhong JH, Xing BC, Zhang WG, Chan AW, Chong CCN, Serenari M, Peng N, Huang T, Lu SD, Liang ZY, Huo RR, Wang YY, Cescon M, Liu TQ, Li L, Wu FX, Ma L, Ravaioli M, Neri J, Cucchetti A, Johnson PJ, Li LQ, Xiang BD. Zhong JH, et al. Among authors: xiang bd. Br J Surg. 2021 Dec 17;109(1):71-78. doi: 10.1093/bjs/znab340. Br J Surg. 2021. PMID: 34643677

6

Letter: older age and male gender increase the risk of hepatocellular carcinoma after hepatitis B surface antigen (HBsAg) seroclearance.

Zhang XY, Jia RR, Xiang X, Gong WF, Xiang BD, Zhong JH, Li LQ. Zhang XY, et al. Among authors: xiang x, xiang bd. Aliment Pharmacol Ther. 2017 Nov;46(9):906-908. doi: 10.1111/apt.14272. Aliment Pharmacol Ther. 2017. PMID: 29023877 No abstract available.

7

Systematic review of risk factors of hepatocellular carcinoma after hepatitis B surface antigen seroclearance.

Kuang XJ, Jia RR, Huo RR, Yu JJ, Wang JJ, Xiang BD, Li LQ, Peng Z, Zhong JH. Kuang XJ, et al. Among authors: xiang bd. J Viral Hepat. 2018 Sep;25(9):1026-1037. doi: 10.1111/jvh.12905. Epub 2018 May 2. J Viral Hepat. 2018. PMID: 29624821 Review.

8

The use of propranolol in the treatment of infantile haemangiomas: an update on potential mechanisms of action.

Ji Y, Chen S, Xu C, Li L, Xiang B. Ji Y, et al. Br J Dermatol. 2015 Jan;172(1):24-32. doi: 10.1111/bjd.13388. Epub 2014 Dec 17. Br J Dermatol. 2015. PMID: 25196392 Review.

9

Comment on: Recovery after breast cancer surgery following a recommendation of physical activity pre- and postoperatively (PhysSURG-B)-a randomized clinical trial.

Li L, Yang X, Zhang Z, Xiang B, Tang X. Li L, et al. Br J Surg. 2021 Aug 19;108(8):e272. doi: 10.1093/bjs/znab132. Br J Surg. 2021. PMID: 33893479 No abstract available.

10

Kaposiform haemangioendothelioma: clinical features, complications and risk factors for Kasabach-Merritt phenomenon.

Ji Y, Yang K, Peng S, Chen S, Xiang B, Xu Z, Li Y, Wang Q, Wang C, Xia C, Li L, Liu X, Lu G, Yang G, Wu H. Ji Y, et al. Br J Dermatol. 2018 Aug;179(2):457-463. doi: 10.1111/bjd.16601. Epub 2018 Apr 24. Br J Dermatol. 2018. PMID: 29603128 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

133 results

Search Page